Abstract
This preliminary nonrandomized study was conducted to evaluate the clinical usefulness of TATI and CYFRA 21-1 as tumor markers in head and neck squamous cell carcinoma. Serum levels of these markers were measured from 122 subjects of a tertiary-care university hospital, divided into four groups: (1) normal individuals and patients with (2) inflammatory pathology, (3) benign tumors and (4) squamous cell carcinoma of the head and neck. Serum samples were collected before and after treatment, with a mean follow-up period of 12 months. The cutoff level, sensitivity, specificity and likelihood ratio of a positive and negative test were: 21 microg/l, 66.6%, 93.75%, 10.6 and 0.35 for TATI; 3.3 microg/l, 28.5%, 95%, 5.7 and 0.75 for CYFRA 21-1, respectively. Both markers presented elevated mean values and statistically significant differences in the cancer patient group compared with the other groups. Significant differences were also observed between the stage of disease and tumor differentiation. TATI levels seem to relate positively to the course of disease during the follow-up period. Although CYFRA 21-1 values presented significant differences, the majority of them were under the cutoff level. We conclude that TATI seems to play a...Continue Reading
Citations
Jul 13, 2002·Cancer·Marcy A ListEverett E Vokes
Mar 20, 2002·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·O PradierC F Hess
Apr 27, 2002·The American Journal of Nursing·Shirley Jordan SeayMelvin Strauss
Jan 9, 2004·Cancer Nursing·Mary Beth HappSarah H Kagan
Apr 28, 2004·Cancer Nursing·Mary Beth HappSarah H Kagan
Aug 2, 2002·The Laryngoscope·Henry C K KwokHamish A Sillars
Apr 6, 2002·Spine·Fengyu ZhengSafdar N Khan
Oct 5, 2006·Journal for Nurses in Staff Development : JNSD : Official Journal of the National Nursing Staff Development Organization·Cherie Smith-Miller
Oct 17, 2002·Oncology·C KuropkatJ A Werner
Mar 19, 2005·Social Work in Health Care·Christine Callahan
Mar 7, 2006·Critical Reviews in Clinical Laboratory Sciences·Annukka Paju, Ulf-Håkan Stenman
Mar 26, 2010·Gynecologic Oncology·Brian NolenAnna Lokshin
Mar 15, 2016·Critical Reviews in Oncology/hematology·Eliete Neves Silva GuerraGraziela De Luca Canto
Sep 13, 2006·International Journal of Oral and Maxillofacial Surgery·L-P ZhongZ-Y Zhang
Nov 16, 2005·The Annals of Otology, Rhinology, and Laryngology·Philippe CéruseFrançois Disant
Aug 25, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A GadducciA R Genazzani
Sep 5, 2019·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Stefan A RudhartStephan Hoch
Dec 15, 2015·Clinical Chemistry·Kati RäsänenUlf-Håkan Stenman
May 14, 2020·International Journal of Molecular Sciences·Milena Matuszczak, Maciej Salagierski
Apr 15, 2020·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Stefan A RudhartStephan Hoch